Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chemotherapy-Induced Febrile Neutropenia × MYL-1401H × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1 Breast 1

Conditions

Neutropenia 1 Chemotherapy-Induced Febrile Neutropenia 1 Breast Neoplasms 1

Interventions

pegfilgrastim 1 MYL-1401H 1 Long-Term Synaptic Depression 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Viatris Inc.

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡